Edward Boas, M.D., Ph.D.
As an interventional radiologist, Edward Boas, M.D., Ph.D., performs minimally invasive procedures using needles and catheters, providing a less invasive alternative to surgery for many patients. This involves guiding a needle or a catheter toward a tumor using computed tomography, ultrasound or X-rays, then burning or freezing the tumor (ablation), blocking its blood supply (embolization) or implanting microscopic radioactive particles to treat it (radioembolization). These procedures can be used to treat cancer in the lung, liver and kidney. He can also reopen blood vessels that are blocked or narrowed by a blood clot or a tumor, using minimally invasive techniques that are performed through a catheter.
Dr. Boas has performed thousands of image-guided procedures and uses a multidisciplinary clinical approach, which involves coordinating care with surgeons, oncologists and other specialists to decide the best treatment strategy for each patient. Dr. Boas teaches other doctors how to perform these procedures at national meetings, and he is a reviewer for several medical journals.
- Interventional radiology
- Diagnostic radiology
- 2008, M.D., Ph.D., Biochemistry, Stanford University
- 2021-present, Associate Clinical Professor, Department of Diagnostic Radiology, City of Hope, Duarte, California
- 2013-2014, Interventional radiology, Hospital of the University of Pennsylvania
- 2009-2013, Radiology, Stanford Hospital
- 2008-2009, General surgery, Stanford Hospital
- 2022, JVIR Editor’s Award for Outstanding Laboratory Investigation
- 2020, The Academy Imaging Shark Tank, best pitch
- 2015, 2016, 2019, Certificate of Recognition for Excellence in Teaching, Department of Radiology, Memorial Sloan Kettering Cancer Center
- 2013, Radiological Society of North America Roentgen Resident/Fellow Research Award
- 2013, American Roentgen Ray Society Residents in Radiology Executive Council Award
Gaba RC, Elkhadragy L, Boas FE, Chaki S, Chen HH, El‐Kebir M, Garcia KD, Giurini EF, Guzman G, LoBianco FV, Neto MF, Newson JL, Qazi A, Regan M, Rund LA, Stewart M, Thomas FM, Whiteley HE, Wu J, Schook LB, Schachtschneider KM. (2020) Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation. Oncotarget. In press.
Deipolyi AR, England RW, Ridouani F, Riedl CC, Kunin HS, Boas FE, Yarmohammadi H, Sofocleous CT. (2020) PET/CT imaging characteristics after radioembolization of hepatic metastasis from breast cancer. Cardiovascular and Interventional Radiology. 43(3): 488‐94.
Sutton C, Zhang Y, Kim D, Yarmohammadi H, Ziv E, Boas FE, Sofocleous CT, Tap WD, D'Angelo SP, Erinjeri JP. (2020) Analysis of the Chemotherapy‐Free Interval Following Image‐Guided Ablation in Sarcoma Patients. Sarcoma. 2020: 3852420.
Borgheresi A, Covey A, Yarmohammadi H, Boas FE, Ziv E, Getrajdman G, Erinjeri J, Jarnagin W, Harding JJ, D'Angelica M, Gonen M, Brown KT. (2019) Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: Analysis of outcome and liver function at disease progression. HPB. In press.
Velayati S, Erinjeri JP, Brody LA, Ziv E, Boas FE, Brown KT, Covey AM, Getrajdman GI, Solomon SB, Kingham PT, Tap WD, Jarnagin WR, Yarmohammadi H. (2019) Safety and efficacy of hepatic artery embolization in treating solitary fibrous tumor metastatic to the liver. Sarcoma. Article ID 3060658.
Boas FE, Brown KT, Ziv E, Yarmohammadi H, Sofocleous CT, Erinjeri JP, Harding JJ, Solomon SB. (2019) Aspirin is associated with improved liver function after embolization of hepatocellular carcinoma. AJR. 213: 689‐95.
Zener R, Yoon H, Ziv E, Covey A, Brown KT, Sofocleous CT, Thornton RH, Boas FE. (2019) Outcomes after transarterial embolization of neuroendocrine tumor liver metastases using spherical particles of different sizes. Cardiovascular and Interventional Radiology. 42: 569‐76.
Maybody M, Muallem N, Brown KT, Moskowitz CS, Hsu M, Zenobi CL, Jihad M, Getrajdman GI, Sofocleous CT, Erinjeri JP, Covey AM, Brody LA, Yarmohammadi H, Deipolyi AR, Bryce Y, Alago W, Siegelbaum RH, Durack JC, Gonzalez‐Aguirre AJ, Ziv E, Boas FE, Solomon SB. (2019) Autologous blood patch injection versus hydrogel plug in CT‐guided lung biopsy: A prospective randomized trial. Radiology. 290: 547‐54.
Kurilova I, Beets‐Tan RGH, Flynn J, Gönen M, Ulaner G, Petre EN, Boas FE, Ziv E, Yarmohammadi H, Klompenhouwer EG, Cercek A, Kemeny NA, Sofocleous CT. (2019) Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre‐Treated Patients With Colon Cancer Liver Metastases. Clinical Colorectal Cancer. 18(1): 8‐18.
Kurilova I, Beets‐Tan RGH, Ulaner GA, Boas FE, Petre EN, Yarmohammadi H, Ziv E, Deipolyi AR, Brody LA, Gonen M, Sofocleous CT. (2018) 90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full‐Strength Contrast Material. Cardiovascular and Interventional Radiology. 41(9): 1419‐27.
Ziv E, Rice SL, Filtes J, Yarmohammadi H, Boas FE, Erinjeri JP, Petre EN, Brody LA, Brown KT, Covey AM, Getrajdman GI, Maybody M, Raj N, Sofocleous CT, Solomon SB, Reidy‐Lagunes D. (2018) DAXX Mutation Status of Embolization‐Treated Neuroendocrine Tumors Predicts Shorter Time to Hepatic Progression. Journal of Vascular and Interventional Radiology. 29(11): 1519‐26.
Deipolyi AR, Riedl C, Bromberg J, Chandarlapaty S, Klebanoff C, Sofocleous CT, Yarmohammadi H, Brody L, Boas FE, Ziv E. (2018) Association of PI3K pathway mutations with early positron‐emission tomography/CT imaging response after radioembolization for breast cancer liver metastases: Results of a single‐center retrospective pilot study. Journal of Vascular and Interventional Radiology. 29(9): 1226‐35.
Currie BM, Getrajdman GI, Covey AM, Alago W, Erinjeri JP, Maybody M, Boas FE. (2018) Push versus pull gastrostomy in cancer patients: A single center retrospective analysis of complications and technical success rates. Diagnostic and Interventional Imaging. 99(9): 547‐53.